Savannah Mendoza used to spend most of her paychecks on food delivery apps and at fast food drive-thrus, trying to satisfy a ...

The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

China: A recent study revealed that combining semaglutide and metformin significantly improved liver inflammation, fibrosis, ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk 's ( NVO 0.15%) stock crashed ...

If a medication shortage is making it difficult for you to access semaglutide through your typical doctor or pharmacy, the ...

Semaglutide and other GLP-1 meds slow the rate at which food empties from your stomach, and that leaves you feeling full ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Nausea is the most common side effect of semaglutide, the ...

It's that time of the year; We all likely indulged more than we'd like to admit for the holidays and put on a few extra ...